Duavee Tablet, Film Coated
Product Images NDC 0008-1123
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Duavee (NDC 0008-1123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Duavee 02)
Logo (Duavee 02a)
Principal Display Panel (15 Tablet Blister Pack)
Principal Display Panel (30 Tablet Blister Pack Pouch)
Principal Display Panel (30 Tablet Blister Pack Pouch Carton)
Duavee® (conjugated estrogens/bazedoxifene) is a medication that comes in a pack of 30 tablets. Each tablet contains 0.45 mg of conjugated estrogens and 20 mg of bazedoxifene. The tablets should not be removed from the blisters until immediately before administration and shouldn't be placed in pill boxes. The recommended storage temperature is 20-25°C with permitted excursions of 15-30°C. The product must be used within 60 days of opening the foil pouch, and it should be kept in the original package to protect from moisture. See the accompanying prescribing information for dosage and use. Distributed by Wyeth Pharmaceuticals, a subsidiary of Pfizer Inc. Made in Ireland.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.